FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069884086> ?p ?o ?g. }

• W2069884086 endingPage "212" @default.
• W2069884086 startingPage "205" @default.
• W2069884086 abstract "Clinical use of antineoplastic drugs is associated with the development of numerous adverse effects that many patients find intolerable, including peripheral neuropathy. Cannabinoids have relieved neuropathic pain in different animal models. But their therapeutic activities could be affected by their psychoactive properties. The aim of this work was to determine the effect of cannabinoids in cisplatin-evoked neuropathy. For this purpose, the non-selective agonist WIN 55,212-2 (WIN), the CB1-selective agonist ACEA or the CB2-selective agonist JWH133 (or their vehicle) was either systemically administered at a non-psychoactive dose or locally injected in cisplatin-treated rats. Selective CB1 and CB2 cannabinoid antagonists (AM251 and SR144528, respectively) were used to characterize cannabinoid effects. Cisplatin-treated rats showed mechanical allodynia but not thermal hyperalgesia. Cannabinoid agonists alleviated mechanical allodynia. This effect was mediated by both CB1 and CB2 cannabinoid receptors when the cannabinoid was systemically applied. At the dose used, cannabinoid agonists had no psychoactive effect. The local effect of the drug involved the activation of peripheral CB1 receptors whereas involvement of CB2 receptors was less clear. In a rat model of cisplatin-induced neuropathy, cannabinoids have an antinociceptive effect, but the cannabinoid receptors involved could be different depending on the route of administration. Non-psychoactive doses of cannabinoid agonists are capable of alleviating the signs of peripheral neuropathy when systemically applied. Interestingly, local administration of selective CB1 agonists or systemic administration of CB2 agonists, which are non-psychoactive, may serve as new therapeutic alternatives for symptom management in painful neuropathy associated with cisplatin treatment." @default.
• W2069884086 created "2016-06-24" @default.
• W2069884086 creator A5036906729 @default.
• W2069884086 creator A5052055862 @default.
• W2069884086 creator A5054862074 @default.
• W2069884086 creator A5059866274 @default.
• W2069884086 date "2013-04-01" @default.
• W2069884086 modified "2023-09-29" @default.
• W2069884086 title "Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy" @default.
• W2069884086 cites W1503107250 @default.
• W2069884086 cites W1505629908 @default.
• W2069884086 cites W1542530495 @default.
• W2069884086 cites W1578820780 @default.
• W2069884086 cites W1829978718 @default.
• W2069884086 cites W1964037009 @default.
• W2069884086 cites W1965319322 @default.
• W2069884086 cites W1968426375 @default.
• W2069884086 cites W1968446992 @default.
• W2069884086 cites W1971941589 @default.
• W2069884086 cites W1972122283 @default.
• W2069884086 cites W1991319303 @default.
• W2069884086 cites W1995048478 @default.
• W2069884086 cites W2008902622 @default.
• W2069884086 cites W2011075878 @default.
• W2069884086 cites W2020010905 @default.
• W2069884086 cites W2022961860 @default.
• W2069884086 cites W2033931579 @default.
• W2069884086 cites W2034264360 @default.
• W2069884086 cites W2035889265 @default.
• W2069884086 cites W2038770419 @default.
• W2069884086 cites W2039106853 @default.
• W2069884086 cites W2065488327 @default.
• W2069884086 cites W2069461625 @default.
• W2069884086 cites W2072744527 @default.
• W2069884086 cites W2076898181 @default.
• W2069884086 cites W2083016614 @default.
• W2069884086 cites W2085803874 @default.
• W2069884086 cites W2090462084 @default.
• W2069884086 cites W2093570206 @default.
• W2069884086 cites W2094267095 @default.
• W2069884086 cites W2096610541 @default.
• W2069884086 cites W2098443650 @default.
• W2069884086 cites W2109653318 @default.
• W2069884086 cites W2113691478 @default.
• W2069884086 cites W2113981135 @default.
• W2069884086 cites W2124248227 @default.
• W2069884086 cites W2125016450 @default.
• W2069884086 cites W2151163164 @default.
• W2069884086 cites W2172242651 @default.
• W2069884086 cites W25380202 @default.
• W2069884086 cites W4237588022 @default.
• W2069884086 doi "https://doi.org/10.1016/j.pbb.2013.02.008" @default.
• W2069884086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23454533" @default.
• W2069884086 hasPublicationYear "2013" @default.
• W2069884086 type Work @default.
• W2069884086 sameAs 2069884086 @default.
• W2069884086 citedByCount "52" @default.
• W2069884086 countsByYear W20698840862013 @default.
• W2069884086 countsByYear W20698840862014 @default.
• W2069884086 countsByYear W20698840862015 @default.
• W2069884086 countsByYear W20698840862016 @default.
• W2069884086 countsByYear W20698840862017 @default.
• W2069884086 countsByYear W20698840862018 @default.
• W2069884086 countsByYear W20698840862019 @default.
• W2069884086 countsByYear W20698840862020 @default.
• W2069884086 countsByYear W20698840862021 @default.
• W2069884086 countsByYear W20698840862022 @default.
• W2069884086 countsByYear W20698840862023 @default.
• W2069884086 crossrefType "journal-article" @default.
• W2069884086 hasAuthorship W2069884086A5036906729 @default.
• W2069884086 hasAuthorship W2069884086A5052055862 @default.
• W2069884086 hasAuthorship W2069884086A5054862074 @default.
• W2069884086 hasAuthorship W2069884086A5059866274 @default.
• W2069884086 hasBestOaLocation W20698840862 @default.
• W2069884086 hasConcept C126322002 @default.
• W2069884086 hasConcept C134018914 @default.
• W2069884086 hasConcept C148001335 @default.
• W2069884086 hasConcept C15490471 @default.
• W2069884086 hasConcept C170493617 @default.
• W2069884086 hasConcept C2776158853 @default.
• W2069884086 hasConcept C2776433454 @default.
• W2069884086 hasConcept C2777107010 @default.
• W2069884086 hasConcept C2777883359 @default.
• W2069884086 hasConcept C2778938600 @default.
• W2069884086 hasConcept C2779245659 @default.
• W2069884086 hasConcept C2779901536 @default.
• W2069884086 hasConcept C2780871563 @default.
• W2069884086 hasConcept C555293320 @default.
• W2069884086 hasConcept C71924100 @default.
• W2069884086 hasConcept C93248783 @default.
• W2069884086 hasConcept C98274493 @default.
• W2069884086 hasConceptScore W2069884086C126322002 @default.
• W2069884086 hasConceptScore W2069884086C134018914 @default.
• W2069884086 hasConceptScore W2069884086C148001335 @default.
• W2069884086 hasConceptScore W2069884086C15490471 @default.
• W2069884086 hasConceptScore W2069884086C170493617 @default.
• W2069884086 hasConceptScore W2069884086C2776158853 @default.
• W2069884086 hasConceptScore W2069884086C2776433454 @default.

• next